Marcia Angell | Academic Influence

Marcia Angell's AcademicInfluence.com Rankings

Marcia Angell

Philosophy

#1508

World Rank

#2725

Historical Rank

#603

USA Rank

Logic

#1314

World Rank

#2031

Historical Rank

#402

USA Rank

philosophy Degrees

Download Badge

Philosophy

Marcia Angell's Degrees

Doctorate Medicine Boston University

Why Is Marcia Angell Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Marcia Angell is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine. She is currently a Senior Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School in Boston, Massachusetts.

(See a Problem?)

Marcia Angell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Alternative medicine--the risks of untested and unregulated remedies. (1998) (714)
The ethics of clinical research in the Third World. (1997) (706)
The Truth About the Drug Companies: How They Deceive Us and What to Do About It (2004) (562)
The Truth About the Drug Companies (2004) (435)
Is academic medicine for sale? (2000) (407)
The journal's policy on cost-effectiveness analyses. (1994) (257)
Losing weight--an ill-fated New Year's resolution. (1998) (254)
Industry-sponsored clinical research: a broken system. (2008) (233)
The quality of mercy. (1982) (210)
The Doctor as Double Agent (1993) (194)
Publish or perish: a proposal. (1986) (162)
Disease as a reflection of the psyche. (1985) (158)
Investigators' responsibilities for human subjects in developing countries. (2000) (155)
Ethical imperialism? Ethics in international collaborative clinical research. (1988) (141)
Privilege and health--what is the connection? (1993) (130)
Patients' preferences in randomized clinical trials. (1984) (129)
Cost containment and the physician. (1985) (128)
Excess in the pharmaceutical industry (2004) (128)
The Ingelfinger Rule revisited. (1991) (120)
Proposal of the Physicians' Working Group for Single-Payer National Health Insurance. (2003) (119)
The case of Helga Wanglie. A new kind of "right to die" case. (1991) (109)
Clinical research--what should the public believe? (1994) (102)
America's other drug problem: how the drug industry distorts medicine and politics. (2002) (101)
Shattuck Lecture--evaluating the health risks of breast implants: the interplay of medical science, the law, and public opinion. (1996) (95)
Quality and the medical marketplace--following elephants. (1996) (93)
Redundant publication: a reminder. (1995) (85)
The pharmaceutical industry--to whom is it accountable? (2000) (84)
The Supreme Court and physician-assisted suicide--the ultimate right. (1997) (82)
Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case (1996) (75)
The Epidemic of Mental Illness: Why? (2010) (71)
Justifying conflicts of interest in medical journals: a very bad idea (2015) (67)
On authorship and acknowledgments. (1991) (67)
"Active" chronic pyelonephritis without evidence of bacterial infection. (1968) (62)
Breast implants--protection or paternalism? (1992) (62)
The Internet and the Journal. (1995) (61)
A dual approach to the AIDS epidemic. (1991) (60)
The Nazi hypothermia experiments and unethical research today. (1990) (57)
Caring for women's health--what is the problem? (1993) (55)
How good is peer review? (1989) (55)
Setting the record straight in the breast-cancer trials. (1994) (51)
Editorials and conflicts of interest. (1996) (47)
Resolved: psychosocial interventions can improve clinical outcomes in organic disease (con). (2002) (46)
Euthanasia in the Netherlands--good news or bad? (1996) (45)
The interpretation of epidemiologic studies. (1990) (44)
Women in medicine: beyond prejudice. (1981) (43)
After Quinlan: the dilemma of the persistent vegetative state. (1994) (43)
Do breast implants cause systemic disease? Science in the courtroom. (1994) (42)
Financial conflicts of interest in biomedical research. (1993) (41)
Negative studies. (1989) (39)
Alcohol and other drugs--toward a more rational and consistent policy. (1994) (39)
Respecting the autonomy of competent patients. (1984) (38)
23. The Illusions of Psychiatry. The New York Review of Books (2012) (36)
Fraud in biomedical research. (1988) (35)
How much will health care reform cost? (1993) (33)
Handicapped children: Baby Doe and Uncle Sam. (1983) (32)
Drug Companies & Doctors: A Story of Corruption (2011) (31)
Evaluation and management guidelines--fatally flawed. (1998) (31)
Disclosure of authors' conflicts of interest: a follow-up. (2000) (30)
Risk adjustment or risk avoidance? (1998) (25)
The Journal and its owner--resolving the crisis. (1999) (24)
Caring for women's health—what is the problem? (1994) (23)
Prisoners of technology--the case of Nancy Cruzan. (1990) (23)
Prepublication release of Journal articles. (1997) (21)
The use of fetal tissue in research on Parkinson's disease. (1992) (20)
Relationships with the drug industry: Keep at arm’s length (2009) (20)
Privatizing health care is not the answer: lessons from the United States (2008) (20)
Violations of the embargo and a new policy on early publicity. (1994) (19)
Colloquium on Scientific Authorship: Rights and Responsibilities (1989) (17)
The high price of product endorsement. (1997) (17)
Redefining physicians' role in assisted dying. (2013) (16)
Caring for the dying--congressional mischief. (1999) (15)
Industry-Sponsored Clinical Research (2008) (15)
Your Dangerous Drugstore (2006) (14)
Moving Forward From the Affordable Care Act to a Single-Payer System. (2016) (13)
Medicine: the endangered patient-centered ethic. (1987) (13)
The Baby Doe rules. (1986) (12)
Resolved: psychosocial interventions can improve clinical outcomes in organic disease--rebuttals and closing arguments. (2002) (12)
Controversial Journal editorials. (2009) (10)
The presidential candidates and health care reform. (1992) (10)
Patients' rights bills and other futile gestures. (2000) (9)
New ways to get pregnant. (1990) (8)
Antipolymer antibodies, silicone breast implants, and fibromyalgia (1997) (8)
Financial conflicts of interest in biomedical research. (1993) (8)
Fixing Medicare. (1997) (7)
The Body Hunters (2005) (7)
Greetings--with regrets. (1980) (6)
The beginning of health care reform: the Clinton plan. (1993) (6)
Redundant Publication (1996) (6)
Should heroin be legalized for the treatment of pain? (1984) (6)
Multiple sclerosis and the Ingelfinger rule. (1983) (4)
Obamacare Confronts a Fiscal Crisis (2013) (4)
Galileo's Tribute: Using Medical Evidence in Court (1997) (4)
A look at ethics and AIDS -- We're trying to help our sickest people, not exploit them In the researcher's code of conduct, contradictions abound. (1997) (4)
Shattering the glass ceiling. (2014) (4)
How the drug industry distorts medicine and politics . America ’ s Other Drug Problem (2015) (4)
On authorship and acknowledgments. (Editorial) (1992) (4)
Case Studies: Please Don't Tell! (1991) (3)
Please don't tell! (1991) (3)
Medicine in the noise age: What can we believe? (2001) (3)
AIDS studies violate Helsinki rights accord. (1997) (3)
What's really behind the attack on silicone breast implants. (1996) (2)
7. Is academic medicine for sale (2012) (2)
ANTIPOLYMER ANTIBODIES, SILICONE BREAST IMPLANTS, AND FIBROMYALGIA. AUTHORS' REPLY (1997) (2)
This Week in the New England Journal of Medicine (1992) (2)
Autoimmune disease and the environment. (1998) (2)
Conflict of interest. (1997) (2)
Perspectives: a medical editor. (1988) (1)
Setting Standards to Avoid Conflict of Interest in Clinical Trials (2002) (1)
Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans. Dr. Angell replies [letter] (1998) (1)
Academic medical centers and conflicts of interest. (2006) (1)
Academic medical centers and conflicts of interest. Authors' reply (2006) (1)
Fraud in biomedical research: a time for congressional restraint. (1988) (1)
Cross-Cultural Considerations in Medical Ethics (2005) (1)
Warning: Doctor/Drug-Company Interactions (2011) (1)
Pregnant at 63? Why not? (1997) (1)
31. The Body Hunters (2019) (0)
Contributors (1980) (0)
Let's stop giving alternative medicine a free ride. Interview by Mark Crane. (2000) (0)
Mother's Day for Women in Medicine-Better Than Roses. (2017) (0)
A look at ethics and AIDS. The argument. (1997) (0)
The public option: Doomed to fail (2009) (0)
Health care reform: a view from the left. (1993) (0)
Conflicts in serving both non-profit and for-profit medical centres (2015) (0)
The role of tax reform in health care reform. (2009) (0)
Cost Containment and the Physician-Reply (1986) (0)
Conflicts of Interest in Clinical Trials (2001) (0)
The Right to Die (1993) (0)
When Money Talks and Science Listens (2004) (0)
Book Review Let's Talk: An Honest Conversation on Critical Issues: Abortion, Euthanasia, AIDS, Health Care By C. Everett Koop and Timothy Johnson. 138 pp. Grand Rapids, Mich., Zondervan, 1992. $8.99. 0-310-59781-1 (1993) (0)
Americans and SI units (1992) (0)
Health care: A tale of two countries (2009) (0)
Disease as a reflection of the psyche. (1985) (0)
WOMEN'S DECISIONS ABOUT ABORTION. REPLY (1993) (0)
DOCTORS AND THE CLINTON PLAN. AUTHOR'S REPLY (1994) (0)
Chapter 1: Is Pharmaceutical Research Safe and Unbiased? (2011) (0)
CROSS-CULTURAL CONSIDERATIONS IN MEDICAL (2005) (0)
Boston University Medicine: v. 4, no. 1, 2 or 3 (1994) (0)
Responding to the AIDS epidemic [1] (1991) (0)
THE ETHICSOFHIVRESEARCH IN DEVELOPINGNATIONS (1998) (0)
ON TmAL : THE CLASH OF MEDICAL EVIDENCE AND THE LAW IN THE BREAST IMPLANT CASE By (2003) (0)
1.: Science and the Public???Who Should the Public Believe? (1997) (0)
JAMA Internal Medicine Peer Reviewers in 2017. (2018) (0)
[The supreme court and assisted suicide: the ultimate right?]. (1998) (0)
How Epidemiology Loses in the Courtroom (2006) (0)
MEDICAL JOURNALS AND THE POPULAR MEDIA. REPLY (1993) (0)

This paper list is powered by the following services:

Other Resources About Marcia Angell

en.wikipedia.org

What Schools Are Affiliated With Marcia Angell?

Marcia Angell is affiliated with the following schools:

Image Attributions

Image Source for Marcia Angell